254 related articles for article (PubMed ID: 30661640)
1. Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
Culyer AJ; Chalkidou K
Value Health; 2019 Jan; 22(1):99-103. PubMed ID: 30661640
[TBL] [Abstract][Full Text] [Related]
2. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
Dolan P; Edlin R
J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
[TBL] [Abstract][Full Text] [Related]
3. Role of Culture, Values, and Politics in the Implementation of Health Technology Assessment in India: A Commentary.
Swami S; Srivastava T
Value Health; 2020 Jan; 23(1):39-42. PubMed ID: 31952672
[TBL] [Abstract][Full Text] [Related]
4. Defining types of economic evaluation.
Ngorsuraches S
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
[TBL] [Abstract][Full Text] [Related]
5. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
[TBL] [Abstract][Full Text] [Related]
6. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
Bala MV; Zarkin GA; Mauskopf JA
Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
[TBL] [Abstract][Full Text] [Related]
7. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.
Pichon-Riviere A; Drummond M; Palacios A; Garcia-Marti S; Augustovski F
Lancet Glob Health; 2023 Jun; 11(6):e833-e842. PubMed ID: 37202020
[TBL] [Abstract][Full Text] [Related]
8. Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?
Feng X; Kim DD; Cohen JT; Neumann PJ; Ollendorf DA
Int J Technol Assess Health Care; 2020 Apr; 36(2):96-103. PubMed ID: 32340631
[TBL] [Abstract][Full Text] [Related]
9. The impact of economic evaluation on quality management in spine surgery.
Boos N
Eur Spine J; 2009 Aug; 18 Suppl 3(Suppl 3):338-47. PubMed ID: 19337760
[TBL] [Abstract][Full Text] [Related]
10. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
Hansen BO; Hougaard JL; Keiding H; Østerdal LP
J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
[TBL] [Abstract][Full Text] [Related]
11. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
Gafni A
Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
[TBL] [Abstract][Full Text] [Related]
12. [Cost-effectiveness and cost-benefit analysis on strategy for preventing mother-to-child transmission of hepatitis B virus].
Cai YL; Zhang SX; Yang PC; Lin Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):846-51. PubMed ID: 27346114
[TBL] [Abstract][Full Text] [Related]
13. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
Leech AA; Kim DD; Cohen JT; Neumann PJ
Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
[TBL] [Abstract][Full Text] [Related]
14. Outcomes measurement: health state preferences and economic evaluation.
Oldridge NB
Assist Technol; 1996; 8(2):94-102. PubMed ID: 10163933
[TBL] [Abstract][Full Text] [Related]
15. Health Years in Total: A New Health Objective Function for Cost-Effectiveness Analysis.
Basu A; Carlson J; Veenstra D
Value Health; 2020 Jan; 23(1):96-103. PubMed ID: 31952678
[TBL] [Abstract][Full Text] [Related]
16. [Neuropharmacoeconomics].
Chiu HC
Acta Neurol Taiwan; 2004 Jun; 13(2):87-96. PubMed ID: 15478681
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for a QALY: theoretical and methodological issues.
Gyrd-Hansen D
Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
[TBL] [Abstract][Full Text] [Related]
18. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
Donaldson C; Birch S; Gafni A
Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
